Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment

Cardiology Research - Canada
doi 10.14740/cr468w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elmer Press, Inc.

Related search

Influence of a Pressure Gradient Distal to Implanted Bare-Metal Stent on In-Stent Restenosis After Percutaneous Coronary Intervention

Circulation
Cardiovascular MedicinePhysiologyCardiology
2007English

Very Late Stent Thrombosis of Bare-Metal Coronary Stent Nine Years After Primary Percutaneous Coronary Intervention

Vojnosanitetski Pregled
MedicinePharmacology
2016English

Predictors of In-Stent Restenosis in Patients Undergoing Percutaneous Coronary Intervention

Demiroğlu Bilim University Florence Nightingale Journal of Medicine
2019English

Stent Selection for Percutaneous Coronary Intervention

Continuing Cardiology Education
2017English

Long-Term Outcomes of Coronary-Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease in the Bare-Metal Stent Era

Circulation
Cardiovascular MedicinePhysiologyCardiology
2008English

Acute Coronary Syndrome After 17 Years of Bare Metal Stent Implantation: “Very” Very Late Stent Thrombosis

Case Reports in Cardiology
Cardiovascular MedicineCardiology
2020English

Acute Lower Limb Ischemia Following Angio-Seal Deployment After Transfemoral Percutaneous Coronary Intervention

Kardiochirurgia i Torakochirurgia Polska
SurgeryCardiovascular MedicineCardiology
2019English

Intracoronary Imaging and Histopathology of Late Phase In-Stent Restenosis After Coronary Stent Implantation

ISRN Vascular Medicine
2012English

Bare Metal Stent Thrombosis in Patients With Acute Coronary Syndrome

Circulation Journal
MedicineCardiovascular MedicineCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy